Protocols for Cutaneous T-Cell Lymphoma
| HIC 0803003592 Francine Foss M.D. Protocol PDX-010: A Phase 1, Open-label Study of Pralatrexate with Vitamin B12 and Folic Acid Supplementation in Patients with Relapsed or Refractory Cutaneous T-cell Lymphoma |
| HIC 0710003117 Francine Foss M.D. Single Agent Phase II Study of Forodesine in the Treatment of Cutaneous T-Cell Lymphoma |